Aliza Thompson

Company: FDA
Job title: Deputy Director of the Division of Cardiology & Nephrology
Seminars:
Panel Discussion: Navigating Earlier Endpoint Development to Predict Clinical Outcome in Shorter Clinical Trials 11:00 am
Can we move towards harmonizing global regulatory endpoints? Non-invasive imaging, patient-reported outcomes, albuminuria and UACR: driving progress in elevating alternative outcome measures Can we incorporate patient reported outcomes in symptomatic kidney diseases?Read more
day: Day One
Regulatory Perspective on Endpoint Development: How is the Regulatory Landscape Evolving with Advances in Research? 9:30 am
Establishing a clinical pathway to correlate promising biomarkers with clinical outcome Advancing understanding of efficacy with the endpoints we already have Evaluating the regulatory landscape for paediatric and ultra-rare clinical studies and driving diversity in clinical trialsRead more
day: Day One